Notably, Fitz et al. reported that while Abca1 deletion in transgenic APP mice caused cognitive deficit at a stage of early amyloid pathology, these characteristics were not observed in Abca1−/−/wildtype mice. Here, ABCA1 is linked to amyloidosis.